Annual Working Capital
$37.17 M
-$237.00 K-0.63%
December 31, 2023
Summary
- As of February 7, 2025, GYRE annual working capital is $37.17 million, with the most recent change of -$237.00 thousand (-0.63%) on December 31, 2023.
- During the last 3 years, GYRE annual working capital has risen by +$2.62 million (+7.58%).
- GYRE annual working capital is now -0.63% below its all-time high of $37.41 million, reached on December 31, 2022.
Performance
GYRE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$40.09 M
+$2.15 M+5.66%
September 30, 2024
Summary
- As of February 7, 2025, GYRE quarterly working capital is $40.09 million, with the most recent change of +$2.15 million (+5.66%) on September 30, 2024.
- Over the past year, GYRE quarterly working capital has increased by +$2.92 million (+7.85%).
- GYRE quarterly working capital is now -7.27% below its all-time high of $43.24 million, reached on March 31, 2024.
Performance
GYRE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
GYRE Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.6% | +7.8% |
| 3 y3 years | +7.6% | +17.3% |
| 5 y5 years | +7.6% | +17.3% |
GYRE Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.6% | +7.6% | -7.3% | +17.3% |
| 5 y | 5-year | -0.6% | +7.6% | -7.3% | +17.3% |
| alltime | all time | -0.6% | +7.6% | -7.3% | +17.3% |
Gyre Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $40.09 M(+5.7%) |
| Jun 2024 | - | $37.95 M(-12.2%) |
| Mar 2024 | - | $43.24 M(+16.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $37.17 M(-0.6%) | $37.17 M(+8.7%) |
| Mar 2023 | - | $34.19 M |
| Dec 2022 | $37.41 M(+8.3%) | - |
| Dec 2021 | $34.56 M | - |
FAQ
- What is Gyre Therapeutics annual working capital?
- What is the all time high annual working capital for Gyre Therapeutics?
- What is Gyre Therapeutics annual working capital year-on-year change?
- What is Gyre Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Gyre Therapeutics?
- What is Gyre Therapeutics quarterly working capital year-on-year change?
What is Gyre Therapeutics annual working capital?
The current annual working capital of GYRE is $37.17 M
What is the all time high annual working capital for Gyre Therapeutics?
Gyre Therapeutics all-time high annual working capital is $37.41 M
What is Gyre Therapeutics annual working capital year-on-year change?
Over the past year, GYRE annual working capital has changed by -$237.00 K (-0.63%)
What is Gyre Therapeutics quarterly working capital?
The current quarterly working capital of GYRE is $40.09 M
What is the all time high quarterly working capital for Gyre Therapeutics?
Gyre Therapeutics all-time high quarterly working capital is $43.24 M
What is Gyre Therapeutics quarterly working capital year-on-year change?
Over the past year, GYRE quarterly working capital has changed by +$2.92 M (+7.85%)